8th International Forum on Rheumatoid Arthritis 2016

21st Fri.-22nd Sat.October,2016 Tokyo

●Chair  Kazuhiko Yamamoto

Department of Allergy and Rheumatology
Graduate School of Medicine, The University of Tokyo

●Venue  Shinagawa Prince Hotel


21st October, Friday

9:50-10:00 Opening ceremony
President Kazuhiko Yamamoto (The University of Tokyo, Japan)
10:00-10:50 Keynote Lecture 1
KL1 The pathophysiology of rheumatoid arthritis in the light of its management
Chair: Kazuhiko Yamamoto (The University of Tokyo, Japan)
Speaker: Josef Smolen (Medical University of Vienna, Austria)
10:50-12:20 Symposium 1
Clinical management of RA
Chair: Shinichi Kawai (Toho University, Japan)
S1-1 Clinical management of RA – benefits and challenges of targeted treatment
Cornelia F Allaart (Leiden University Medical Center, Netherlands)
S1-2 Clinical management of RA〜Toward personalization
Tsutomu Takeuchi (Keio University, Japan)
S1-3 Comorbidity on the outcome of patients with rheumatoid arthritis
Hisashi Yamanaka (Tokyo Women's Medical University, Japan)
12:40-13:30 Luncheon Seminar1
LS1 The Role of Anti-Citrullinated Protein Antibodies (ACPA) in the Pathogenesis of Rheumatoid Arthritis
Chair: Akio Morinobu (Kobe University Hospital , Japan)
Speaker: William H. Robinson (Stanford University, USA)
13:40-15:10 Oral Presentation 1
Chair:     Hajime Kono (Teikyo University, Japan)
Kanae Kubo (The University of Tokyo, Japan)
OP1-1 Comparison of effectiveness of abatacept and adalimumab in patients with rheumatoid arthritis by a propensity score-matching: study from FIRST registry
Satoshi Kubo (University of Occupational and Environmental Health, Japan)
OP1-2 Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study
Hua Zhu (Peking University People's Hospital , China)
OP1-3 Targeting ultrasound remission strategy is associated with a better control of rheumatoid arthritis disease activity
Yan Geng (Peking University First Hospital , China)
OP1-4 Diverse effects of biological DMARDs on peripheral immune phenotypes in patients with rheumatoid arthritis
Shingo Nakayamada (University of Occupational and Environmental Health, Japan)
OP1-5 Tendency to choose first biologic agent therapy of rheumatoid arthritis in the elderly: Results from Japanese multicenter registry
Tatsuo Watanabe (Nagoya University, Japan)
OP1-6 Cardiac Morphology and Function in Patients with Acute Coronary Syndrome Complicated with Rheumatoid Arthritis
Lili Pan (Beijing An Zhen Hospital Capital Medical University, China)
15:10-16:40 Symposium 2
Various aspects of arthritis
Chair: Toshihide Mimura (Saitama Medical University, Japan)
S2-1 2015 ACR RA treatment guideline: The Current Paradigm of RA treatment
Jasvinder A Singh (University of Alabama, USA)
S2-2 High remission and low relapse with prolonged intensive DMARD therapy (PRINT) in rheumatoid arthritis
Zhanguo Li (People's Hospital, Beijing University, China )
S2-3 IL-6 and TNF-α induced upregulation of CCR5 and CXCR3 Participate in Vδ2 Chemotaxis in Rheumatoid Arthritis
Zhang Xuan (Peking Union Medical College(PUMC) Hospital, China)
16:50-17:40 Sponsored Seminar
SS Safety and efficacy of iguratimod in patients with active rheumatoid arthritis: a multicenter, large cohort, real world study
Chair: Seiji Minoda (Jichi Medical University, Japan)
Speaker: Zhanguo Li (People's Hospital, Beijing University, China)
17:50-18:40 Evening Seminar
ES Rheumatoid Arthritis: Optimizing Treatment Paradigms
Chair: Naoki Ishiguro (Nagoya University, Japan)
Speaker: Arthur Kavanaugh (University of California, San Diego, USA)
18:50-19:50 Poster Session
20:00-22:00 Welcome Reception
at Room “Opal 17”, Main Tower 17th Floor, Shinagawa Prince Hotel

22nd October, Saturday

9:20-10:10 Morning Seminar
Chair: Tsuneyo Mimori (Kyoto University, Japan)
MS-1 Recent advances in RA treatment with bDMARDs in Japan
Speaker: Hideto Kameda (Toho University (Ohashi Medical Center), Japan)
MS-2 Recent progress in JAK inhibitors for the treatment of rheumatoid arthritis
Speaker: Yoshiya Tanaka (University of Occupational and Environmental Health, Japan)
10:20-11:10 Keynote Lecture 2
KL2 From Triggering to targeting. New aspects of the pathogenesis of RA
Chair: Yoshinari Takasaki (Juntendo Koshigaya Hospital, Juntendo University, Japan)
Speaker: Lars Klareskog (Karolinska Institutet/Karolinska University Hospital, Sweden)
11:10-12:40 Symposium 3
Pathogenesis of RA
Chair: Masataka Kuwana (Nippon Medical School, Japan)
S3-1 Genetics of rheumatoid arthritis: Functional insights from genetic information
Kazuhiko Yamamoto (The University of Tokyo, Japan)
S3-2 Studies of At-Risk Populations Provide Insights into the Origins, Pathogenesis and Prevention of Rheumatoid Arthritis
Michael Holers (University of Colorado, USA)
S3-3 TBC
Huji Xu (Shanghai Changzheng Hospital, China)
13:00-13:50 Luncheon Seminar 2
LS2 Targeting IL-6 as a key molecule involved in the pathogenesis of inflammatory rheumatic diseases
Chair: Tatsuya Atsumi (Hokkaido University, Japan)
Speaker: Frank Buttgereit (Charité Universitätsmedizin Berlin, Germany)
14:00-15:30 Oral Presentation 2
Chair:     Shigeto Toma (National Hospital Organization Sagamihara National Hospital, Japan)
Tetsuji Sawada (Tokyo Medical University Hospital, Japan)
OP2-1 The inhibitory effect of soluble form of gp130, sgp130, on the regulation of inflammatory status in rheumatoid arthritis
Kazuyuki Yoshizaki (Osaka University, Japan)
OP2-2 Impairment of Granzyme B-producing B cells exacerbated Rheumatoid arthritis
Liling Xu (Peking University People's Hospital, China)
OP2-3 Lipopolysaccharide-binding protein is a sensitive disease activity biomarker for ESR/CRP negative RA patients and associated with metabolic disorder
Xiaolin Sun (Peking University People's Hospital, China)
OP2-4 Pathogenic conversion of regulatory B10 cells into osteoclast-priming cells in rheumatoid arthritis
Fanlei Hu (Peking University People's Hospital, China)
OP2-5 The role of ubiquitin-binding proteins in rheumatoid arthritis synovial fibroblasts
Masaru Kato (Hokkaido University, Japan)
OP2-6 The Comprehensive Analysis for the Transcriptional Organization of Stimuli Responses in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients
Haruka Tsuchiya (The University of Tokyo, Japan)
15:30-17:00 Symposium 4
Future treatment
Chair: Hitoshi Kohsaka (Tokyo Medical and Dental University, Japan)
S4-1 Safety and efficiency of low-dose Interleukin-2 treatment in Systemic Lupus Erythematosus
Xiaolin Sun (Peking University People's Hospital)
S4-2 Recent advances and future therapy with biologics in rheumatoid arthritis (Tentative)
Yeong-Wook Song (Seoul National University Hospital)
S4-3 Understanding of immunological pathogenesis of rheumatoid arthritis for future treatment
Keishi Fujio (The University of Tokyo, Japan)